JAK2 V617F mutation in essential thrombocythemia: Clinical associations and long-term prognostic relevance.

被引：0
|
作者：
Wolanskyj, AP
Lasho, TL
Schwager, SM
McClure, RF
Wadleigh, M
Lee, SJ
Gilliland, DG
Tefferi, A
机构：
[1] Mayo Clin, Rochester, MN USA
[2] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
254
引用
收藏
页码：77A / 78A
页数：2
相关论文
共 50 条
  • [1] The JAK2 V617F mutation in essential thrombocythemia
    Cho, Young-Uk
    Chung, Hee-Jung
    Chi, Hyun-Sook
    Jang, Seoungsoo
    Park, Chan-Jeoung
    Lee, Jung-Hee
    Lee, Je-Hwan
    Lee, Kyoo-Hyung
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2007, 29 : 103 - 103
  • [2] Clinical implications of the JAK2 V617F mutation in essential thrombocythemia
    Antonioli, E
    Guglielmelli, P
    Pancrazzi, A
    Bogani, C
    Verrucci, M
    Ponziani, V
    Longo, G
    Bosi, A
    Vannucchi, AM
    LEUKEMIA, 2005, 19 (10) : 1847 - 1849
  • [3] Clinical implications of the JAK2 V617F mutation in essential thrombocythemia
    E Antonioli
    P Guglielmelli
    A Pancrazzi
    C Bogani
    M Verrucci
    V Ponziani
    G Longo
    A Bosi
    A M Vannucchi
    Leukemia, 2005, 19 : 1847 - 1849
  • [4] JAK2 V617F mutation in essential thrombocythemia.
    Ahn, Jeong Yeal
    Park, Pil Whan
    Seo, Yiel Hea
    Shin, Dong-Bok
    Lee, Jae-Hoon
    Yoo, Soo-Jin
    Bang, Soo-Mee
    BLOOD, 2006, 108 (11) : 318B - 318B
  • [5] JAK2V617F mutation in essential thrombocythaemia:: clinical associations and long-term prognostic relevance
    Wolanskyj, AP
    Lasho, TL
    Schwager, SM
    McClure, RF
    Wadleigh, M
    Lee, SJ
    Gilliland, DG
    Tefferi, A
    BRITISH JOURNAL OF HAEMATOLOGY, 2005, 131 (02) : 208 - 213
  • [6] Assessment of JAK2 V617F mutation in Tunisian patients with essential thrombocythemia
    Belhiba, M.
    Bellaaj, H.
    Keskes, L.
    Frikha, R.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 1016 - 1016
  • [7] Prognostic relevance of JAK2 V617F mutation in primary myelofibrosis
    Barosi, G.
    Bergamaschi, G.
    Marchetti, M.
    Massa, M.
    Rosti, V.
    Bonetti, E.
    Vannucchi, A. M.
    Guglielmelli, P.
    Antonioli, E.
    Campanelli, R.
    Villani, L.
    Viarengo, G. L.
    Barbui, T.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 241 - 241
  • [8] 2 DIFFERENT PHENOTYPES IN ESSENTIAL THROMBOCYTHEMIA: MUTATION JAK2 V617F OR CALR
    Vilches Moreno, A. S.
    Guerrero Fernandez, L.
    Latorre Gonzalez, A.
    Monteagudo Saiz, D.
    Robles Marina, V
    Andreu Costa, A.
    Ayala Diaz, R.
    Martinez Lopez, J.
    HAEMATOLOGICA, 2016, 101 : 187 - 187
  • [9] JAK2 V617F polycythemia vera and essential thrombocythemia: dynamic clinical features associated with long-term outcomes
    Sureau, Lea
    Buors, Caroline
    Ianotto, Jean-Christophe
    Boyer, Francoise
    Tanguy-Schmidt, Aline
    Roy, Lydia
    Cayssials, Emilie
    Cailly, Laura
    Chomel, Jean-Claude
    Chauveau, Aurelie
    Orvain, Corentin
    Mansier, Olivier
    Ranta, Dana
    Robles, Margot
    Gyan, Emmanuel
    Herault, Olivier
    Nimubona, Stanislas
    Marchand, Tony
    Lippert, Eric
    Riou, Jeremie
    Ugo, Valerie
    Luque Paz, Damien
    BLOOD CANCER JOURNAL, 2022, 12 (04)
  • [10] JAK2 V617F polycythemia vera and essential thrombocythemia: dynamic clinical features associated with long-term outcomes
    Léa Sureau
    Caroline Buors
    Jean-Christophe Ianotto
    Françoise Boyer
    Aline Tanguy-Schmidt
    Lydia Roy
    Emilie Cayssials
    Laura Cailly
    Jean-Claude Chomel
    Aurélie Chauveau
    Corentin Orvain
    Olivier Mansier
    Dana Ranta
    Margot Robles
    Emmanuel Gyan
    Olivier Hérault
    Stanislas Nimubona
    Tony Marchand
    Eric Lippert
    Jérémie Riou
    Valérie Ugo
    Damien Luque Paz
    Blood Cancer Journal, 12
12345